Loss of the Human Cytomegalovirus US16 Protein Abrogates Virus Entry into Endothelial and Epithelial Cells by Reducing the Virion Content of the Pentamer by Luganini, Anna et al.
Loss of the Human Cytomegalovirus
US16 Protein Abrogates Virus Entry into
Endothelial and Epithelial Cells by
Reducing the Virion Content of the
Pentamer
Anna Luganini,a Noemi Cavaletto,a Stefania Raimondo,b Stefano Geuna,b
Giorgio Gribaudoa
Department of Life Sciences and Systems Biology,a and Department of Clinical and Biological Sciences,b
University of Torino, Turin, Italy
ABSTRACT The human cytomegalovirus (HCMV) US12 gene family encodes a group
of predicted seven-transmembrane proteins whose functions have yet to be estab-
lished. While inactivation of individual US12 members in laboratory strains of HCMV
does not affect viral replication in fibroblasts, disruption of the US16 gene in the
low-passage-number TR strain prevents viral growth in endothelial and epithelial
cells. In these cells, the US16-null viruses fail to express immediate early (IE), early
(E), and late (L) viral proteins due to a defect which occurs prior to IE gene expres-
sion. Here, we show that this defective phenotype is a direct consequence of defi-
ciencies in the entry of US16-null viruses in these cell types due to an impact on the
gH/gL/UL128/UL130/UL131A (pentamer) complex. Indeed, viral particles released from
fibroblasts infected with US16-null viruses were defective for the pentamer, thus
preventing entry during infections of endothelial and epithelial cells. A link between
pUS16 and the pentamer was further supported by the colocalization of pUS16 and
pentamer proteins within the cytoplasmic viral assembly compartment (cVAC) of in-
fected fibroblasts. Deletion of the C-terminal tail of pUS16 reproduced the defective
growth phenotype and alteration of virion composition as US16-null viruses. How-
ever, the pentamer assembly and trafficking to the cVAC were not affected by the
lack of the C terminus of pUS16. Coimmunoprecipitation results then indicated that
US16 interacts with pUL130 but not with the mature pentamer or gH/gL/gO. To-
gether, these results suggest that pUS16 contributes to the tropism of HCMV by in-
fluencing the content of the pentamer into virions.
IMPORTANCE Human cytomegalovirus (HCMV) is major pathogen in newborns and
immunocompromised individuals. A hallmark of HCMV pathogenesis is its ability to
productively replicate in an exceptionally broad range of target cells. The virus in-
fects a variety of cell types by exploiting different forms of the envelope glycopro-
tein gH/gL hetero-oligomers, which allow entry into many cell types through differ-
ent pathways. For example, incorporation of the pentameric gH/gL/UL128/UL130/
UL131A complex into virions is a prerequisite for infection of endothelial and epithelial
cells. Here, we show that the absence of US16, a thus far uncharacterized HCMV
multitransmembrane protein, abrogates virus entry into endothelial and epithelial
cells and that this defect is due to the lack of adequate amounts of the pentameric
complex in extracellular viral particles. Our study suggests pUS16 as a novel viral
regulatory protein important for shaping virion composition in a manner that influ-
ences HCMV cell tropism.
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Human cytomegalovirus (HCMV) is a major opportunistic pathogen in individualswith acquired or developmental deficiencies in innate and adaptive immunity.
Indeed, HCMV is the leading viral cause of congenital disease and a common cause of
morbidity and mortality in AIDS patients and organ transplant recipients (1–3). The
pathogenesis of HCMV diseases is greatly influenced by the exceptionally broad range
of target cells into which the virus can enter and then productively replicate. Indeed,
among the HCMV-susceptible cell types, the predominant targets for massive produc-
tive viral replication in the natural host are fibroblasts of connective tissues, epithelial
cells of mucosal tissue and glands, smooth muscle cells in the gastrointestinal tract, and
vascular endothelial cells (3–6).
In order to infect such a remarkable range of different cell types successfully, each
type with its own unique biochemical characteristics, HCMV has evolved the ability
to exploit multiple and ubiquitous cell receptors, and it has developed a generous
glycoprotein coding capacity such that it can form different and, in some cases, modular
envelope complexes that mediate interactions with different cellular receptors (6, 7).
Prototypical examples of such a modular virion complex are the two glycoprotein
gH/gL-containing multimeric complexes that regulate virus cell tropism through inter-
action with cell-type-specific receptors and that trigger virus entry via direct interaction
with the fusion protein gB (6–8). In fact, in HCMV virions, gH/gL can be either part of
the gH/gL/gO trimer or part of the pentameric complex (pentamer) formed between
gH/gL and the UL128, UL130, and UL131A proteins (8). HCMV entry into fibroblasts
requires gH/gL/gO and arises through direct fusion with the cell plasma membrane
while entry into endothelial and epithelial cells, dendritic cells, and monocytes involves
macropinocytosis or endocytosis and low-pH-dependent fusion with endosomes and
requires the pentamer (6–8). Thus, the proteins UL128 to UL131 represent major viral
determinants of endothelial and epithelial cell tropism since mutation or deletion of
any of the corresponding genes impairs HCMV entry into these cell types (5–7).
However, the results of genome-wide and functional studies point toward the
existence of additional HCMV genes required for the successful completion of the viral
infection cycle in endothelial and epithelial cells (9–11). In this regard, we observed that
inactivation of the US16 gene in the low-passage-number TR strain severely impaired
virus replication in different types of endothelial and epithelial cells (12) and in
dendritic cells (A. Luganini and G. Gribaudo, unpublished data). US16 belongs to the
US12 gene family that includes a set of 10 contiguous genes arranged in tandem (US12
to US21) in the unique short (US) region of the HCMV genome (11, 13). This gene family
has been identified only in cytomegaloviruses specific to higher primates, such as
rhesus CMV (RhCMV) and chimpanzee CMV (CCMV) (13). The identification of putative
seven-transmembrane hydrophobic domains in each of the US12 open reading frames
(ORFs) would predict a common structural framework that associates these proteins
with cellular membranes (13). Deletion of individual family members or even the entire
US12 locus from the genome of HCMV laboratory strains did not influence viral
replication in fibroblasts (9, 10). Consequently, it has been hypothesized that the US12
genes may exert regulatory roles in the infection of specific cell types and/or under
different physiological conditions in vivo (13). Their pronounced conservation among
different HCMV strains supports their importance and requirement during HCMV
infection in the host (11). Nonetheless, the expression, localization, and functions of
most of the US12 proteins remain to be defined.
In our previous report, we observed that US16-mutant viruses failed to express
representative immediate early (IE), early (E), and late (L) viral proteins and to deliver the
tegument protein pp65 and incoming viral DNA to nuclei in infected endothelial and
epithelial cells, thus suggesting that the US16 gene regulates, in a cell-type-specific
manner, a phase of the HCMV replication cycle occurring after virion attachment but
prior to the release of the viral genome into the nucleus (12). Nevertheless, a direct role
of US16 in viral entry into endothelial and epithelial cells was unlikely as no US16
protein could be detected in extracellular virus particles purified from culture super-
natants of HCMV-infected fibroblasts (12). This observation led us to hypothesize that
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pUS16 could modulate some entry-related events even though it is not incorporated
into virions.
The present study addresses this hypothesis by investigating the role of US16
protein in the entry process of an endothelio- and epitheliotropic HCMV strain. Spe-
cifically, inactivation of the US16 ORF impaired entry of US16-null viruses into endo-
thelial and epithelial cells, and this defect correlated with the absence of representative
pentamer proteins in purified extracellular virions produced by a US16-null virus.
However, even in the absence of functional pUS16, neither the trafficking of the
pentamer to the cytoplasmic viral assembly compartment (cVAC) nor cVAC formation
was altered, thus suggesting that pUS16 contributes to determine the final glycopro-
tein composition of the envelope of HCMV particles in a manner that influences the
virus cell tropism.
RESULTS
Inactivation of the US16 gene abrogates entry of HCMV into endothelial and
epithelial cells. To investigate whether entry into endothelial and epithelial cells was
defective in US16-mutant viruses, ARPE-19 cells, an in vitro epithelial cell model, were
infected with wild-type (wt) TR (TRwt), TRΔUS16, or TRUS16stop (Fig. 1) or with the
AD169 or Towne strain, two HCMV strains defective for entry into endothelial and
epithelial cells (5–7). Cells were then briefly treated with 44% polyethylene glycol (PEG),
reported to overcome defects in virus entry in the entry-defective UL128-to-UL150
deletion mutant from strain TR when the virus is adsorbed to the cell surface of
epithelial cells (14). Infection rates were assessed at 24 h postinfection (p.i.) by indirect
immunofluorescence detection of IEA (IE1 plus IE2) proteins. As shown in Fig. 2A (left
panel), the PEG treatment greatly increased the percentage of epithelial cells infected
with TRΔUS16 or TRUS16stop to levels almost similar to the level observed with TRwt
(on average, 8% was observed for TRΔUS16, 12% for TRUS16stop, and 13% for TRwt).
Quantitative microscopic analysis showed more than a 40-fold increase in the fre-
quency of IEA detection following the treatment of TRΔUS16- or TRUS16stop-infected
cells with PEG (Fig. 2A, right panel), thus indicating that US16-deficient viruses, like
AD169 and Towne, were defective for entry into epithelial cells.
FIG 1 A schematic representation of the HCMV US16 and UL130 gene regions and the modifications introduced
into the ORFs. In TRΔUS16, the US16 ORF was replaced with a cassette containing the galK-kan genes. In
TRUS16stop, a single nucleotide change was introduced into codons 9, 10, and 11 of the US16 ORF. These changes
created a stop codon in the 10th codon (12). The TRUS16HA-UL130V5 was generated from TRUS16HA-ΔUL130 BAC
by reintroducing the UL130 ORF fused with the coding sequence for a V5 epitope tag at its C terminus. In the
TRΔUS16-UL130V5, the US16 ORF was replaced with the galK-kan cassette. In TRUS16HAΔC-UL130V5, the galK-kan
gene of TRΔUS16-UL130V5 BAC was replaced with a C-terminal truncation of the US16 ORF lacking 34 amino acids
(from 276 to 309) fused in frame with an HA epitope tag at its C terminus. Recombinant BACs were examined for
the desired mutations by PCR and sequencing. UL, unique long region; IRS, short inverted repeat; RL, long inverted
repeat; TRS, short terminal repeat.
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To support this observation further and to investigate the fate of viral particles
generated by a US16-deficient virus, we performed ultrastructural analysis by transmis-
sion electron microscopy in the other cell type tested, i.e., endothelial cells. To this end,
human dermal microvascular endothelial cells (HMVECs) were infected with purified
TRwt or TRΔUS16 virus particles at a multiplicity of infection (MOI) of 30 and then
processed for electron microscopy at 2 and 24 h p.i. As shown in Fig. 2B, at 2 h p.i., both
viruses were internalized, and virions and dense bodies were found to accumulate in
vacuoles within the cytoplasm of infected HMVECs. However, at 24 h p.i., more than
FIG 2 The US16 gene is required for entry into endothelial and epithelial cells. (A) Effect of PEG on the
infection rate of US16-mutant viruses in epithelial cells. ARPE-19 cells were infected with TRwt, AD169,
Towne, TRΔUS16, or TRUS16stop (MOI of 0.1 PFU/cell), centrifuged at 2,000 rpm for 30 min, and then
incubated at 37°C for 2 h. Infected cells were then treated with either PBS or 44% PEG for 60 s. At 24 h
p.i., cells were fixed, permeabilized, and stained with an anti-IEA (IE1IE2) MAb. Immunofluorescence
experiments were repeated three times, and representative microscope fields are shown (left). Images
from cells infected with AD169 or TRΔUS16 and then left untreated were purposely chosen to include
some positive nuclei to show virus addition since random fields were generally negative for IEA staining.
Magnification,10. The average percentages of the ratio of IEA-positive nuclei to DAPI-stained nuclei for
20 different microscope fields are shown (right). Data shown are the means  SD. **, P  0.001; ***, P 
0.0001, for results with the indicated viruses versus those with the calibrator sample (cells infected with
TRwt, AD169, Towne, TRΔUS16, or TRUS16stop, and then not treated with PEG). (B) US16-deficient virus
fails to release viral particles from endocytic vesicles in endothelial cells. HMVECs were infected with TRwt
or TRΔUS16 (MOI of 30 PFU/cell) at 4°C for 2 h. Infected cells were then incubated at 37°C and, at
the indicated times, fixed, embedded, and sectioned for transmission electron microscopy. Representa-
tive micrographs of three independent experiments are shown (left). Filled black arrows indicate mature
virions; open arrows show dense bodies. Magnification,40,000. Scale bar (top left), 0.5 m. The average
percentages of virus particles counted inside endosomes are shown (right). Eight fields were analyzed for
each of 10 cells evaluated for each virus at 2 and 24 h p.i. Data shown are the means  SD. ***, P 
0.0001, for results with the indicated viruses versus those with the calibrator sample (2 h p.i. versus 24 h
p.i.).
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70% of the TRΔUS16 virions present in cells at early times of infection could still be
detected within cytoplasmic vesicles while TRwt particles were no longer observed in
the cytoplasm of infected HMVECs (Fig. 2B, right panel); this observation is consistent
with the accepted model of TR entry into endothelial cells, which involves macropi-
nocytosis or endocytosis and the release of nucleocapsids from the vesicles following
the low-pH-dependent fusion with endosomes (7, 8, 14, 15).
Taken together, these results suggest that an intact US16 ORF is required in the
producer cells (e.g., fibroblasts) to generate viral particles capable of entry into both
endothelial and epithelial cells.
HCMV virions produced by US16-null virus are defective for pentamer pro-
teins. The presence of an adequate content of the pentamer in virions is a prerequisite
for successful infection of endothelial and epithelial cells (6–8). Therefore, to test
whether the defective phenotype of genotypically US16-negative viruses was associ-
ated with a change of the pentamer abundance, extracellular virus particles harvested
from supernatants of human foreskin fibroblast (HFF) cultures infected with TRwt or
TRΔUS16 were purified by ultracentrifugation (12), and their protein compositions were
compared by immunoblot analysis with the protein extracts prepared from TRwt- and
TRΔUS16-infected HFFs. The presence of representative pentamer proteins, such as
pUL128 and pUL130, was assessed along with that of UL99 (pp28), UL83 (pp65), gB, and
gH as a control for tegument and envelope glycoproteins. Golgin-97, a protein asso-
ciated with the cytoplasmic face of the trans-Golgi network (TGN) and observed in the
cVAC of HCMV-infected fibroblasts (16), was analyzed to control for cell membrane
contamination and was not detected in the purified extracellular particles (Fig. 3). The
relative abundances of UL99, UL83, and gB were not significantly different between
virions produced by TRwt and TRΔUS16, while a reduced gH content was observed in
extracellular virus particles released from cells infected with the US16-deficient virus
(Fig. 3). However, the most substantial differences were measured for pUL128 and
pUL130. As expected, these two pentamer proteins were observed in TRwt particles
and in the corresponding infected cell extracts and in extracts prepared from TRΔUS16-
infected HFFs (Fig. 3). In contrast, the pUL128 and pUL130 contents in TRΔUS16 virions
were reduced to virtually undetectable levels in comparison to the levels seen in TRwt;
FIG 3 Inactivation of the US16 gene impairs incorporation of pentamer proteins into viral particles. TRwt
and TRΔUS16 extracellular virion particles were purified from culture supernatants of infected HFFs by
centrifugation through 20% sorbitol cushions. Protein extracts prepared from virions (V) or infected cells
(C) were then fractionated through SDS-PAGE gels and analyzed by immunoblotting with mouse MAbs
specific for gH, gB, UL83, UL99, UL128, or UL130. Immunodetection of golgin-97, a marker for the
trans-Golgi network, was performed as a control for cell protein contamination. Molecular mass markers
are indicated for each panel.
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this suggested that the defective entry of US16-deficient viruses was due to the
absence of adequate levels of the pentamer. Moreover, the fact that the levels of
pUL128 and pUL130 observed in TRΔUS16-infected HFFs were similar to those in
TRwt-infected cells (Fig. 3) indicated that the lack of the US16 gene did not affect their
expression proteins but, rather, the subsequent stages of pentamer maturation, such as
its formation or trafficking and/or incorporation into mature viral particles.
pUS16 and representative pentamer proteins colocalize within the cVAC of
producing cells. To investigate in more depth the relationship between pUS16 and the
pentamer pathway in the context of the viral replication cycle, we generated two
further derivatives of TRwt. In TRUS16HA-UL130V5 (Fig. 1), the US16 ORF is expressed
as a fusion protein with a hemagglutinin (HA) epitope tag sequence at its carboxyl
terminus, and the UL130 ORF is expressed as a fusion protein with a V5 epitope tag at
its carboxyl terminus. In the TRΔUS16-UL130V5 derivative (Fig. 1), the US16 coding
region of the TRUS16HA-UL130V5 bacterial artificial chromosome (BAC) was replaced
with a galK-kan cassette. The expression levels of tagged pUS16HA and pUL130V5 were
examined by immunoblot analysis of total cell protein extracts prepared at different
times p.i. from HFFs infected with TRUS16HA-UL130V5 or with TRΔUS16-UL130V5 (Fig.
4A). pUS16HA and pUL130V5 were both first detected at 48 h p.i. and persisted until 96
h p.i. As expected, the expression of pUS16HA was not observed in cells infected with
the US16-null TRΔUS16-UL130V5 virus. The replication kinetics of TRUS16HA-UL130V5
and TRΔUS16-UL130V5 showed no apparent differences on HFFs (data not shown),
while those of TRUS16HA-UL130V5 in HMVECs and ARPE-19 cells (Fig. 4B) were similar
to those of TRwt. In contrast, the disruption of the US16 coding region in TRΔUS16-
UL130V5 caused, as expected, a severe growth defect in both HMVECs and ARPE-19
cells (Fig. 4B), as previously seen in TRΔUS16 and TRUS16stop viruses (12). Altogether,
these results validate the use of TRUS16HA-UL130V5 and TRΔUS16-UL130V5 viruses as
appropriate initial tools for investigating the intracellular location of pUS16HA and
pUL130V5 in infected cells by means of immunofluorescence.
Since HCMV infection induces a profound reorganization of several components of
the cellular secretory machinery that rearrange during late stages of infection into the
cytoplasmic virion assembly complex (VAC) (17–20), we wanted to investigate whether
pUS16 accumulates within the VAC. To this end, in HCMV-infected HFFs we examined
the localization of pUS16 and three cellular organelle markers, GM130 (a cis-medial
Golgi complex marker), EEA1 (an early endosomal marker), and CD63 (a late endosome
marker), that are all reorganized by HCMV infection toward the periphery (pUS16) and
the center (the organelle markers) of the cVAC (17, 18). In HFFs infected with
TRUS16HA-UL130V5 for 120 h p.i., by which time the cVAC is fully formed (17, 18),
pUS16HA showed a distinctive ring-like cytoplasmic staining pattern with remarkable
overlap of the GM130 pattern (Fig. 5A). The ring-like structure revealed by staining with
the anti-GM130 monoclonal antibody (MAb) is the consequence of HCMV-induced
remodeling of GM130-containing Golgi stacks within the cytoplasm of uninfected cells
and corresponds to the peripheral cylinder structure of the cVAC (17, 18). When
TRUS16HA-UL130V5-infected HFFs were immunostained for pUS16HA and EEA1 or for
CD63, the pUS16HA-positive ring-like cytoplasmic structure partially overlapped the
structures of the other two markers in the periphery of the cVAC (Fig. 5A). Moreover,
pUS16-HA partially colocalized within the periphery of cVAC with gH and gB, two viral
glycoproteins that are known to accumulate in the cVAC (19) and that showed a more
concentrated staining pattern in the central part of the cVAC (Fig. 5A).
The intracellular localization of pUS16HA relative to that of pUL130V5 was then
investigated at time points spanning the entire HCMV replication cycle in TRUS16HA-
UL130V5-infected HFFs (Fig. 5B). Consistent with the immunoblot analysis (Fig. 4A),
pUS16 staining was first detectable at 48 h p.i. and, similar to staining of pUL130V5,
displayed a diffuse pattern throughout the cytoplasm of infected cells up to 72 h p.i.
(Fig. 5B). As infection progressed, starting from 96 h p.i., the intracellular localizations
of both pUS16HA and pUL130V5 changed as they began to display a staining pattern
similar to that of GM130 in infected cells, with the characteristic ring-like shape, which
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became increasingly evident at 120 h p.i. when most of the pUS16HA and pUL130V5
staining overlapped within the ring-like structure (Fig. 5B), thus indicating that in the
context of infection, the two proteins colocalized in the periphery of the cVAC. Multicell
assessment of the Pearson’s coefficient of colocalization (21) confirmed that pUS16HA
and pUL130V5 have higher levels of colocalization with gB and gH than pUS16HA
(Fig. 5C).
This last observation led us to investigate the membrane topology of pUS16 relative
to the intraluminal localization of pUL130 (22). The potential transmembrane domain
(TMD) regions of pUS16 were predicted using five different algorithms: Phyre, version
2.0 (23), MEMSAT3 (24), MEMSAT_SVM (24), TopPred, version 0.01 (25), and TMHMM,
version 2.0 (26). All algorithms were consistent in predicting a cytoplasmic N terminus.
However, two different topology profiles were proposed: one with six TMDs (TMHMM,
version 2.0) and another with seven TMDs (Phyre, version 2.0, MEMSAT3, MEMSAT_
FIG 4 Characteristics of TRUS16HA-UL130V5 and TRΔUS16-UL130V5 viruses. (A) Kinetics of pUS16HA and
pUL130V5 protein expression. HFFs were mock infected (lane M) or infected with TRUS16HA-UL130V5 or
TRΔUS16-UL130V5 (MOI of 1 PFU/cell). At the indicated times p.i., total protein cell extracts were
prepared, fractionated by SDS-PAGE, and analyzed by immunoblotting with anti-HA or anti-V5 MAb. The
immunodetection of tubulin with an MAb was performed as an internal control. (B) Replication of
TRUS16HA-UL130V5 and TRΔUS16-UL130V5 in endothelial and epithelial cells. HMVECs and ARPE-19 cells
were infected with the parental TRwt, TRUS16HA-UL130V5, or TRΔUS16-UL130V5 (MOI of 0.1 PFU/cell).
The extent of virus replication was determined by plaque assay in HFFs. The data shown are the averages
of three experiments  SD.
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SVM, and TopPred, version 0.01). To address this discrepancy and to determine whether
the C terminus of pUS16HA was cytosolic or luminal, an epitope accessibility assay was
adopted after the selective permeabilization of HFFs with either 20 M digitonin, to
permeabilize the plasma membrane only (leaving internal membranes, such as the
Golgi apparatus and the endoplasmic reticulum [ER], intact), or with 0.1% Triton X-100,
which allows complete permeabilization and antibody accessibility to epitope tags
regardless of their orientation within any membrane (27). The cellular markers GM130
(a protein that is tightly bound to the cytosolic side of cis-Golgi membranes) (28) and
calreticulin (a luminal ER protein) (29), along with UL83 (pp65) (a tegument protein that
accumulates in the cytoplasm late in infection) (30) and gB and gH (luminal viral
glycoproteins), were used to validate the selective permeabilization assay for detection
of membrane-associated cytosolic or luminally oriented epitopes (Fig. 6). The orienta-
FIG 5 pUS16 accumulates in the cVAC of infected cells and colocalizes with pUL130 within the peripheral
zone. (A) pUS16HA localizes within the cVAC. HFFs were infected with TRUS16HA-UL130V5 (MOI of 1
PFU/cell) or mock infected. At 120 h p.i., the cells were fixed, permeabilized, and stained for pUS16HA
(green) and for GM130 (Golgi marker), EEA1 (early endosomal marker), CD63 (late endosomal marker), gB,
and gH (red). (B) pUS16HA colocalizes with pUL130V5 in the periphery of cVAC at late times during
infection. HFFs were infected with TRUS16HA-UL130V5 (MOI of 1 PFU/cell) or mock infected, and at
various times p.i. cells were fixed, permeabilized, and immunostained with an anti-HA and anti-V5 MAbs.
Immunofluorescence experiments were repeated three times; representative images visualized by confocal
microscopy are presented. Magnification, 60. (C) Colocalization coefficients for pairs of viral markers.
Pearson’s correlation for colocalization of signals between pUS16HA and gB, gH, or pUL130 was
determined in confocal microscopy images collected from experiments included in panels A and B. Ten
randomly chosen fields were evaluated for each pair of makers. The data shown are the averages of three
independent experiments  SD.
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tion of the C terminus of pUS16 relative to that of pUL130 was thus determined by
staining TRUS16HA-UL130V5-infected HFFs with both anti-V5 and anti-HA MAbs. How-
ever, only Triton X-100 treatment allowed immunostaining of the C terminus of pUS16
(Fig. 6B), thus demonstrating that it was located on the luminal side of a cVAC
membrane, most likely a Golgi complex-derived compartment as suggested by the
overlap of the pUS16 and GM130 staining in the periphery of the cVAC (Fig. 5); these
results argue in support of the predicted seven-TMD topology of pUS16. Moreover, the
staining of pUL130 was observed only after Triton X-100 permeabilization, as expected
from the accepted model of the pentamer structure in which gL, pUL128, pUL130, and
pUL131A are all bound to the intraluminal/extracellular portion of gH (6–8).
Taken together, the results shown in this section indicate that pUS16 is a seven-TMD
protein that colocalizes late in infection with pUL130 within Golgi complex-derived
vesicles of the cVAC.
The C-terminal tail of pUS16 is essential for efficient HCMV replication in endo-
thelial and epithelial cells. To investigate the importance of the pUS16 C-terminal tail
in conferring the virus tropism for endothelial and epithelial cells, we generated a
derivative of TRUS16HA-UL130V5 BAC, the TRUS16HAΔC-UL130V5 BAC, in which the
US16HA gene is replaced with an HA-tagged C-terminal truncation variant lacking the
last 34 amino acids (from 276 to 309) of the wt US16 ORF (Fig. 1). The expression levels
of pUS16HA and pUS16HAΔC were examined in HFFs infected with TRUS16HA-
UL130V5 or with TRUS16HAΔC-UL130V5 (Fig. 7A). As expected, both proteins were
detected starting from 48 h p.i. and remained detectable until 96 h p.i. The
molecular mass of the pUS16HAΔC protein band, about 29 kDa, detected by the
anti-HA MAb was smaller than that of pUS16HA (Fig. 7A) and fits well the predicted
size of pUS16HAΔC (31 kDa), thus confirming the successful truncation of the C
terminus of the US16 ORF. Next, we compared the growth kinetics of TRUS16HA-
UL130V5, TRUS16HAΔC-UL130V5, and, as a control, TRΔUS16-UL130V5 in HMVECs
and ARPE-19 cells. Replication of TRUS16HAΔC-UL130V5 in HFFs was similar to that
of TRUS16HA-UL130V5 (data not shown). However, in both HMVECs and ARPE-19
FIG 6 C-terminal topology of pUS16 and pUL130. HFFs were infected with TRUS16HA-UL130V5 (MOI of
1 PFU/cell), and at 96 and 120 h p.i. cells were selectively or completely permeabilized using digitonin
(Digitonin) or Triton X-100 (Triton) or not permeabilized (NP). The pUS16 and pUL130 C-terminal tags
were then immunostained with MAbs to HA and V5, respectively. GM130 and calreticulin (CALR) staining
was used as a control of mock-infected cells (A). gB, gH, and UL83 (pp65) staining was used to control
for selective permeabilization of infected cells (B). Images are representative of three independent
experiments. Magnification, 60.
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cells, TRUS16HAΔC-UL130V5 exhibited a severe growth defect similar to that ob-
served for TRΔUS16-UL130V5 (Fig. 7B). Thus, deletion of the C-terminal tail of US16,
as in TRUS16HAΔC-UL130V5, phenocopies the defective growth in endothelial and
epithelial cells seen for US16-deficient viruses in which the whole US16 ORF
was deleted or inactivated (Fig. 4) (12). Finally, immunoblot analysis of purified
TRUS16HAΔC-UL130V5 virions produced by infected HFFs showed that deletion of
the last C-terminal 34 amino acid residues of pUS16 reduced to undetectable levels
the content of pUL128 and pUL130 in extracellular virus particles (Fig. 7C), as
previously observed in genotypically negative US16 virions, such as those of
TRΔUS16 (Fig. 3).
Altogether, these results point toward a role of the pUS16 C-terminal tail in causing
the defective growth in endothelial and epithelial cells, as well as the specific alteration
of the virion content of the pentamer already observed for US16-null mutant viruses.
FIG 7 Truncation of the C-terminal tail of pUS16 impairs HCMV replication in endothelial and epithelial
cells as well as incorporation of pentamer proteins into extracellular viral particles. (A) Kinetics of
pUS16HA and pUS16HAΔC protein expression. HFFs were mock infected (lane M) or infected with
TRUS16HA-UL130V5 or TRUS16HAΔC-UL130V5 (MOI of 1 PFU/cell), and at 24, 48, 72, and 96 h p.i. total
protein cell extracts were prepared, fractionated by SDS-PAGE, and analyzed by immunoblotting with the
anti-HA or anti-V5 MAb. The immunodetection of tubulin with an MAb was performed as an internal
control. (B) TRUS16HAΔC-UL130V5 fails to replicate in endothelial and epithelial cells. HMVECs and
ARPE-19 cells were infected with TRUS16HA-UL130V5, TRUS16HAΔC-UL130V5, or TRΔUS16-UL130V5
(MOI of 0.1 PFU/cell). The extent of virus replication was then assessed by titrating the infectivity of
supernatants by plaque assay in HFFs. The data shown are the average of three experiments  SD. (C)
Effects of the C-terminal truncation of pUS16 on the levels of pentamer proteins incorporated into
extracellular virions. TRUS16HA-UL130V5 and TRUS16HAΔC-UL130V5 extracellular virion particles were
purified from culture supernatants of infected HFFs by centrifugation through 20% sorbitol cushions.
Protein extracts prepared from virions (V) or infected cells (C) were then fractionated by SDS-PAGE and
analyzed by immunoblotting with mouse MAb specific for gH, gB, UL128, or V5 to detect pUL130 protein.
Immunodetection of calreticulin, as an endoplasmic reticulum marker, was performed as a control for cell
protein contamination.
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The pUS16 C terminus is not required for assembly and trafficking of the
pentamer. To investigate the impact of the deletion of the C-terminal segment of
pUS16 on the pentamer pathway, we first analyzed formation of the pentameric
complex in HFFs infected with TRUS16HA-UL130V5 or TRUS16HAΔC-UL130V5 by co-
immunoprecipitation (co-IP). The data shown in Fig. 8 indicate that gH, pUL128, and
pUL130V5 could be detected in anti-V5 immunoprecipitates from extracts of either
TRUS16HA-UL130V5- or TRUS16HAΔC-UL130V5-infected HFFs, thus indicating that the
absence of the C-terminal tail of pUS16 did not affect the assembly of the complex. The
specificity of the co-IP assay was verified by the lack of detection of both the control gB,
a viral glycoprotein not predicted to interact with UL130, and the pentamer proteins in
V5 immunoprecipitates from the untagged TRwt infection (Fig. 8). Then, the subse-
quent stage of the pentamer complex maturation, namely, its trafficking from the ER,
where it assembles (8), to the cVAC, was examined by immunofluorescence in cells
infected with TRUS16HA-UL130V5 or TRUS16HAΔC-UL130V5. As shown in Fig. 9, in
HFFs infected for 120 h, the pUS16HAΔC expressed by TRUS16HAΔC-UL130V5 (right
panel) showed the same ring-like staining pattern as full-length pUS16 (left panel),
demonstrating that the C-terminal deletion did not affect the trafficking of pUS16HAΔC
to the cVAC. Similarly, the staining patterns of pUL130, gH, gB, and of tested cVAC
markers (GM130, EEA1, and CD63) were akin to the patterns observed in TRUS16HA-
UL130V5-infected cells (Fig. 9, left panel), thus indicating that deletion of the pUS16
C-terminal tail did not affect the trafficking of representative pentamer proteins to the
cVAC or efficient cVAC formation. Moreover, immunolocalization of pUL130 and
pUS16HAΔC showed the entirely overlapping ring-like, cytoplasmic staining pattern of
the two proteins (Fig. 9, right panel), as already observed for the full-length pUS16HA
(Fig. 9, left panel, and 5B).
Therefore, these results indicate that the C-terminal tail of pUS16 is not necessary for
cVAC formation or the assembly and trafficking of the pentamer from the ER to the site
of virus maturation and envelopment.
pUS16 and pUL130 interact in infected cells. The above results made it plausible
that the link between the pUS16 and the pentamer might involve interactions between
pUS16 and components of the complex. To investigate this hypothesis, co-IP assays
were performed on protein extracts prepared from HFFs infected with TRUS16HA-
UL130V5 or TRUS16HAΔC-UL130V5. As shown in Fig. 10A, we were able to detect gH,
pUL130V5, pUL128, and gO but not pUS16HA in anti-gH immunoprecipitates of
TRUS16HA-UL130V5-infected cells. However, we detected pUL130V5 and, as expected,
pUS16HA but not gH, gO, and pUL128 in immunoprecipitates for HA (Fig. 10B).
Reciprocally, pUS16HA along with gH and pUL128 was observed in immunoprecipitates
for V5 from the same cell lysates that contained the tagged pUL130 (Fig. 10C). In
FIG 8 The C-terminal tail of the US16 protein is not required for the formation of the pentameric
complex. HFF cells were infected with TRwt, TRUS16HA-UL130V5, or TRUS16HAΔC-UL130V5 (MOI of 1
PFU/cell). At 120 h p.i., cell extracts were prepared and immunoprecipitated using anti-V5 MAb. Then,
immunoprecipitates and input cell extracts were analyzed by immunoblotting for detection of gH, gB,
pUL128, and the V5 epitope.
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contrast, we could not detect pUL130V5 in anti-HA immunoprecipitates from
TRUS16HAΔC-UL130V5-infected cell extracts (Fig. 10D), suggesting that the C-terminal
tail of pUS16 might be involved in the interaction with pUL130. Finally, lack of detection
of proteins from control IgG IP as well as of the negative-control UL83 (Fig. 10, pp65)
indicated that our anti-gH, anti-HA, and anti-V5 immunoprecipitates were specific for
gH-, pUS16-, and pUL130-interacting proteins.
Taken together, these co-IP results suggest that pUS16, while not being able to
directly interact with the mature pentamer complex or with gH/gL/gO, can associate
with pUL130.
DISCUSSION
In a previous report, we observed that disruption of the US16 ORF in the genome
of a low-passage-number HCMV strain impairs its ability to replicate in cell types that
are major targets for productive lytic replication and dissemination in the natural host,
such as endothelial and epithelial cells (12). In these cells, the replicative cycle of
different US16-deficient viruses was blocked at a stage prior to the expression of IE
genes; moreover, pUS16 could not be detected in purified virions produced from
fibroblasts infected with US16-deficient viruses (12). However, this leaves open the
question as to how pUS16 regulates certain pre-IE phases of the replication cycle in
endothelial and epithelial cells even though it is not incorporated into virions released
from producing cells.
Here, we provide evidence supporting the idea that the defective growth pheno-
FIG 9 Lack of the C-terminal tail of pUS16 does not affect the trafficking of pentamer proteins to the
cVAC of infected cells. HFF cells were infected with TRUS16HA-UL130V5 or TRUS16HAΔC-UL130V5 (MOI
of 1 PFU/cell). At 120 h p.i., the cells were fixed, permeabilized, and stained green for pUS16HA and red
for GM130, EEA1, CD63, V5, gB, or gH. Protein localization was visualized by confocal microscopy.
Immunofluorescence experiments were repeated three times, and representative results are presented.
Magnification, 60.
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type of genotypically US16-negative virions in endothelial and epithelial cells is a
consequence of deficiencies in the entry phase in these cell types. This failure has been
related to a severe reduction of the pentamer content of extracellular viral particles
produced in fibroblasts infected with US16-mutant viruses lacking either the whole
US16 ORF or its C-terminal tail. However, in producer cells (i) the expression of
representative pentamer proteins was not altered (Fig. 3 and 7), (ii) the pentameric
complex was assembled correctly (Fig. 8), and (iii) the pentamer was normally trans-
ported to the cVAC (Fig. 9). Therefore, pUS16 seems to be dispensable for pentamer
formation and trafficking to the site of secondary virus envelopment. Nonetheless,
pUS16 was found to be required for the production of virus progeny with a high
pentamer content. The lack of detectable interactions between pUS16 and the mature
pentamer (Fig. 10), however, makes unlikely a direct action of pUS16 in the incorpo-
ration of the complex into virions. Currently, therefore, we can speculate that pUS16
would operate indirectly in the final maturation of endothelio- and epitheliotropic virus.
The absence of pUS16 from extracellular viral particles (12), on the other hand, may
support a role of pUS16 as an indirect producer-cell modifier of virion composition.
Thus, in this scenario, pUS16 could promote interactions between not yet identified
viral and/or cellular protein(s) and the mature pentamer that, in turn, mediate the
efficient recruitment of pentamer-rich vesicles to tegumented nucleocapsids (3, 19).
In-depth characterization of the protein-protein interactions that occur between pUS16
and other proteins in infected cells should prove helpful in sustaining or disproving this
model.
Alternatively, one could speculate that pUS16 could prevent the retention in pro-
FIG 10 Interaction between pUS16 and pUL130 in infected cells. HFF cells were infected with TRUS16HA-
UL130V5 or TRUS16HAΔC-UL130V5 (MOI of 1 PFU/cell). At 120 h p.i., cell extracts were prepared and
immunoprecipitated using anti-gH (A), anti-HA (B, and D), and anti-V5 (C) MAbs or a nonspecific control
IgG. Immunoprecipitates alongside input cell lysates were then analyzed by immunoblotting for detec-
tion of gO, gH, UL83 (pp65), pUL128, and the HA and V5 epitopes.
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ducing cells of virus particles with a high pentamer content by interfering with the
interaction between the pentamer and its specific cellular receptor. This would be
consistent with the observation that genotypically US16-negative virions can efficiently
infect other fibroblasts only due to the release of viral particles containing only
gH/gL/gO. In this regard, it has been reported that fibroblasts infected with a low-
passage-number HCMV release progeny composed of distinct endotheliotropic and
nonendotheliotropic virus populations and that the endotheliotropic population has a
high pentamer content (31). However, it is unlikely that the absence of pUS16 in
producer cells affects the release of pentamer-rich virions because fibroblasts appar-
ently do not express the receptor for the pentamer that is thought to be expressed in
endothelial and epithelial cells (5–8) and that may be the molecule responsible for
retaining the endotheliotropic HCMV population, as has been suggested in infected
endothelial cells (31). Therefore, we may envisage that it is the lack of the specific
incorporation of the pentamer into enveloped viruses, and not a defect in release of
virions, that is responsible for the defective phenotype of US16-null viruses produced
in fibroblasts.
Although an interaction of pUS16 with the pentamer was not observed, it was
intriguing that there was an interaction between pUS16 and the pUL130 and that this
interaction was prevented by the deletion of the C-terminal tail of pUS16 (Fig. 10), thus
suggesting a possible involvement of this segment of pUS16 in binding pUL130. The
absence of pUS16 in immunoprecipitates for gH from TRUS16HA-UL130V5-infected
cells (Fig. 10A), on the other hand, suggests that pUS16 may bind a pUL130 surface that
is sterically hindered in the assembled pentamer. The importance of the pUS16-pUL130
interaction for the incorporation of the pentamer, however, remains to be determined.
In this regard, an interaction has been reported between pUL130 and the human
Snapin protein, a component of the SNARE complex required for synaptic vesicle docking
and exocytosis (32, 33), which may suggest a role of this interaction in pentamer
incorporation and/or release of virions endowed with adequate amounts of the
complex.
Another HCMV protein that regulates virus cell tropism by affecting the pentamer is
UL148. In a recent study, it was reported that pUL148 modulates HCMV tropism by
regulating the relative abundance of the two alternative gH/gL complexes on mature
viral particles and that pUL148 exerts this effect during the assembly and/or maturation
of the two complexes (34). pUL148 localizes to the ER and is not detected in the cVAC
of HCMV-infected HFFs, while co-IP studies indicate interactions between pUL148 and
several components of the two alternative gH/gL complexes during their assembly
within the ER (34). In the proposed model, pUL148, by competing with pUL128 for
loading onto immature gH/gL, selectively promotes the formation of the gH/gL/gO
heterotrimer. Therefore, it was concluded that pUL148 impacts HCMV cell tropism by
modulating the assembly of gH/gL complexes (35, 36). Here, we observed that pUS16
localizes to the cVAC, does not affect the assembly or the intracellular abundance of the
pentameric complex, and does not physically interact with the mature pentamer.
pUS16 thus influences the abundance of the pentamer in virions with a mechanism
different from that exerted by UL148. Nevertheless, it is conceivable that both pUL148
and pUS16 contribute to shaping the final glycoprotein composition of the envelope of
infectious virions by affecting the amounts and the incorporation of the pentamer,
respectively, and in this way influencing the tropism of progeny virus.
Work from recent years from our and other laboratories supports the view that the
US12 gene family encodes a series of regulatory proteins that impact different HCMV-
host cell interactions. In fact, inactivation of some US12 gene members affects virus-
mediated manipulation of the host innate immune response (37, 38) or, as we reported
for US16 (12) and US20 (39), HCMV cell tropism. However, irrespective of the final
outcome for virus-host cell interactions, the functions of several US12 proteins appear
to be related to the late stages of HCMV maturation and the fine-tuning of the most
appropriate protein composition of virions (38; this study). In this regard, identification
of the luminal C-terminal tail of pUS16 as a domain required for HCMV’s tropism for
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endothelial and epithelial cells supports the hypothesis that during the course of the
evolution of the US12 gene family, an ancestral host-derived flexible structural protein
scaffold associated with cellular membranes adapted to new purposes, fulfilling differ-
ent and specific functions (13). In this model, changes occurring in the highly divergent
N- and C-terminal amino acid sequences in the different US12 ORFs may have allowed
the development of specific interactions with other cellular and/or viral proteins that,
in turn, may regulate a broad range of specific activities within the infected cell. Further
proteomics analyses by mass spectrometry of pUS16-containing protein complexes
isolated from HCMV-infected cells may shed light on the global network of interactions
occurring between pUS16 and other viral and/or cellular proteins and thus help to
elucidate the details of the mechanism(s) through which pUS16 affects the acquisition
of an envelope rich in the pentamer and thereby influences HCMV infectivity in
clinically relevant cell types.
MATERIALS AND METHODS
Oligonucleotides. All oligonucleotides for PCR, mutagenesis, and sequencing were obtained from
Life Technologies. Those used for BAC mutagenesis are listed in Table 1.
Bioinformatics. US16 topology was predicted using the Phyre, version 2.0, MEMSAT3, MEMSAT_SVM,
TMHMM, version 2.0, and TopPred, version 0.01, programs. ClustalW, version 1.8, was used to identify
amino acid sequence alignments.
Cells. Low-passage-number primary human foreskin fibroblasts (HFFs) were grown in Dulbecco’s
modified Eagle’s medium (DMEM) (Biowest) supplemented with 10% fetal bovine serum (FBS) (Biowest).
Human dermal microvascular endothelial cells (HMVECs) (CC-2543) were obtained from Clonetics and
cultured as previously described (12). The retinal pigment epithelial cell line ARPE-19 (ATCC CRL-2302)
was cultured in a 1:1 mixture of DMEM and Ham’s F12 medium (Life Technologies) supplemented with
10% fetal calf serum (FCS).
Viruses. The HCMV laboratory strain AD169 was purchased from ATCC (VR538). The HCMV Towne
bacterial artificial chromosome (BAC) (40) was a gift from Wolfram Brune. The wild-type TR BAC (NCBI
accession no. AC146906.1) (41) was a gift from Jay Nelson. Reconstitution of the TR BAC in fibroblasts
generated infectious virus that retained the ability to infect endothelial and epithelial cells (14).
Construction of TRΔUS16, TRUS16stop, and TRUS16HA mutants (Fig. 1) was described previously (12).
The TRUS16HA-UL130V5 BAC (Fig. 1) was generated by a two-step replacement strategy using the galK
recombineering method, as previously described (12, 39, 42, 43). Briefly, in the first step the galK-kan
cassette was amplified out of the pGalK-Kan plasmid (a gift from Dong Yu) by PCR using the UL130_galK/
kan primer set (Table 1). Specific sequences at the 3= ends of the forward and reverse primers (21 and
20 bp, respectively) dictated the amplification of the galK cassette, and their 5=-end 50-bp tails were
homologous to the sequences flanking the UL130-UL131 genes between nucleotides 213889 and 212641
of the complete TR BAC sequence. Following PCR, the PCR product was digested with DpnI to remove
any plasmid template, gel purified, and then electroporated into SW102 bacteria harboring TRUS16HA
BAC (12). The galK-kan cassette in TRUS16HA-ΔUL130 BAC was replaced in the second step with the
UL130V5 cassette (amplified by PCR from the TR BAC using the UL130V5 primer set) (Table 1) that fused
a sequence encoding a V5 epitope tag (GKPIPNPLLGLDST) to the C terminus of the UL130 ORF.
Gal-negative colonies were characterized for replacement of the galK-kan sequences with the mutated
UL130 version by PCR amplification of the whole segment, followed by restriction enzyme analysis and
sequencing.
To generate the TRΔUS16-UL130V5 BAC (Fig. 1), the US16HA ORF in TRUS16HA-UL130V5 BAC was
replaced with the galK-kan cassette amplified from pGalk-Kan using the US16_galK/kan primer set
(Table 1).
The TRUS16HAΔC-UL130V5 BAC was derived from the TRΔUS16-UL130V5 BAC by replacing the
galK-kan cassette with the US16HAΔC cassette (amplified by PCR from the TR BAC by the US16HAΔC
primer set) (Table 1). In the US16HAΔC cassette, the HA epitope tag is fused in frame at the C terminus
TABLE 1 Oligonucleotides used for BAC mutagenesis
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of a truncated derivative of the US16 ORF in which the last 34 amino acids (from 276 to 309) have been
deleted (Fig. 1).
Two independent TRUS16HA-UL130V5, TRΔUS16-UL130V5, and TRUS16HAΔC-UL130V5 BAC clones
were selected and characterized to ensure that their phenotypes did not result from off-target mutations.
Infectious recombinant TRΔUS16, TRUS16stop, TRUS16HA-UL130V5, TRΔUS16-UL130V5,
TRUS16HAΔC-UL130V5, TRwt, and Towne viruses were reconstituted in HFFs by transfection of the
corresponding BAC DNA as previously described (12, 39). Viral titers were determined by plaque
assay in HFFs.
Extracellular viral particles were concentrated from culture supernatants of HCMV-infected cells at 8
days p.i. by centrifugation at 6,000  g for 1 h at 4°C and then partially purified through a 20% sorbitol
cushion at 50,000  g for 1 h at 4°C (12).
PEG-induced fusion. Treatment with polyethylene glycol (PEG) to stimulate the fusion between
virion and cellular membranes was performed as previously described by Ryckman et al. (14). Briefly,
ARPE-19 cells cultured in 24-well plates were infected with TRwt, AD169, Towne, TRUS16stop, or
TRΔUS16 at an MOI of 0.1 PFU/cell, then immediately centrifuged at 2,000 rpm for 30 min, and incubated
at 37°C for 2 h. Thereafter, cells were washed twice with warm phosphate-buffered saline (PBS), treated
with 44% (vol/vol) PEG (Fluka) in PBS at 37°C for 60 s, and then washed immediately five times with warm
PBS. After 24 h p.i., the number of IEA-positive cells was evaluated by immunofluorescence analysis.
Immunofluorescence. Immunofluorescence analysis was performed as previously described (12, 39)
using the rat monoclonal antibody (MAb) anti-hemagglutinin (anti-HA) (clone 3F10; Roche) and mouse
MAbs against V5 (clone R960-25; Life Technologies), IEA (IE1 plus IE2) (clone E13; Argene Biosoft), GM130
(clone 35/GM130; BD Biosciences), EEA1 (clone 14/EEA1; BD Biosciences), calreticulin (CALR) (clone
16/calreticulin; BD Biosciences), CD63 (sc-5275; Santa Cruz), gB (clone CH28; Virusys), gH (sc-58113; Santa
Cruz), and UL83 (clone 3A12; Virusys). Selective permeabilization assays were performed as previously
described (27).
The binding of primary antibodies was detected with CF594-conjugated rabbit anti-mouse IgG
antibodies (Sigma) or with CF488A-conjugated rabbit anti-rat IgG (Sigma). Nuclei were counterstained
with 4,6-diamidino-2-phenylindole (DAPI) where indicated in the legend to Fig. 2. Samples were then
visualized with an Olympus IX50 fluorescence microscope equipped with Image-Pro Plus software. The
intracellular localization of proteins was examined using an Olympus IX70 inverted laser scanning
confocal microscope, and images were captured using FluoView 300 software (Olympus Biosystems). For
quantitative colocalization of proteins, confocal microscopy images were analyzed to evaluate the
Pearson’s correlation coefficient by ImageJ as described by Adler and Parmryd (21).
Transmission electron microscopy. Prechilled HMVECs were infected with precooled purified TRwt
or TRΔUS16 virus at an MOI of 30 PFU/cell at 4°C for 2 h. The cells were incubated at 37°C for 2 or 24
h and then processed for transmission electron microscopy. Infected cell pellets were fixed in a solution
of 1.25% glutaraldehyde (Fluka, St. Louis, MO, USA), 1% paraformaldehyde (Merck, Darmstadt, Germany),
and 0.5% sucrose in 0.1 M Sörensen phosphate buffer (pH 7.2) for 2 h at 4°C. Pellets were then washed
in 0.1 M Sörensen phosphate buffer (pH 7.2) with 1.5% sucrose for 6 to 12 h, postfixed in 1 to 2% osmium
tetroxide, dehydrated in ethanol, washed twice for 7 min with propylene oxide, and then embedded in
Glauert’s embedding mixture of resins, consisting of equal parts of araldite M and araldite Härter, plus
HY 964 (Merck, Darmstadt, Germany), supplemented with 0.5% of the plasticizer dibutyl phthalate. Then,
2% of the accelerator DY 064 (Merck, Darmstadt, Germany) was added. Thin sections (70 nm) were cut
using a Leica Ultracut UCT, stained with uranyl acetate and lead citrate, and examined with a JEM-1010
transmission electron microscope (JEOL, Tokyo, Japan) equipped with a MegaView III digital camera and
a Soft Imaging System (SIS, Münster, Germany) for the computerized acquisition of images.
Immunoblotting and coimmunoprecipitation assay. For immunoblotting, the protein extractions,
determination of protein concentrations, and immunoblot analysis were performed as previously de-
scribed (12, 39). Immunostaining was carried out with a mouse MAb against V5 or with a rat anti-HA MAb
conjugated to horseradish peroxidase (clone 3F10; Roche). Mouse MAbs against tubulin (clone TUB 2.1;
Sigma), golgin-97 (sc-59820; Santa Cruz), and calreticulin (CALR) were used as controls for cellular protein
loading. Immunostaining of proteins extracted from purified virions was carried out with mouse MAbs
against V5, UL83, UL99 (clone CH19; Virusys), gB, and gH. Mouse MAbs against pUL128 (clone 4B10) and
pUL130 (clone 3C5), were provided by Giuseppe Gerna. Immunocomplexes were detected with goat
anti-mouse immunoglobulin antibodies conjugated to horseradish peroxidase (Life Technologies) and
visualized by enhanced chemiluminescence (Western blotting Luminol reagent; Santa Cruz).
For coimmunoprecipitation, mock-infected and infected HFFs were lysed in Triton buffer (20 mM
Tris-Cl, pH 6.8, 100 mM NaCl, 1% Triton X-100, 25 l/ml protease inhibitor cocktail [P8340; Sigma]) and
clarified by centrifugation at 16,000  g (4°C for 30 min). Aliquots of 400 g of protein were incubated
at 4°C overnight with rotation with an anti-HA affinity matrix (clone 3F10), MAb against V5, mouse MAb
against gH (clone 14-4B) (44, 45) (a gift from Bill Britt), or with control normal mouse IgG (Sigma); then
immune complexes were collected using Protein A/G Plus agarose (Pierce). Beads were pelleted and
washed three times with lysis buffer and boiled with Laemmli sample buffer, and supernatants were
analyzed by immunoblotting with MAbs anti-V5, anti-HA, anti-gH (clone AP86) (46) (a gift from Bill Britt),
anti-UL128, and anti-UL83 or with a rabbit polyclonal antipeptide antibody raised against HCMV TB40/e
gO (47), kindly provided by Brent Ryckman.
Statistical analysis. All data are presented as means  standard deviations (SD). The data were
analyzed for significance using a paired t test and were considered statistically significant at a P value
of0.05. All statistical tests were performed using GraphPad Prism, version 5.01, for Windows (GraphPad
Software).
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